Event Brief
Mar 30, 2026 at 7:05 AM ET
Eli Lilly partners with Insilico for AI drug development
By The BriefBrief
Eli Lilly has secured a deal with Insilico Medicine for AI-driven drug discovery worth up to €2.39 billion.
WHO: Eli Lilly
WHAT: partnership for AI-designed drug development
WHEN: Mar 30, 2026 at 6:46 AM ET
WHERE: USA
WHY: to accelerate the discovery and development of novel therapeutics
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
